The DOI matches its Crossref record, with a small difference in title or year; 26 of the 26 references it cites were found in a registry or an index.
Cognitive Behavior Therapy and Pharmacotherapy for Insomnia: A Randomized Controlled Trial and Direct Comparison
Abstract
Background Chronic sleep-onset insomnia is a prevalent health complaint in adults. Although behavioral and pharmacological therapies have been shown to be effective for insomnia, no placebo-controlled trials have evaluated their separate and combined effects for sleep-onset insomnia. The objective of this study was to evaluate the clinical efficacy of behavioral and pharmacological therapy, singly and in combination, for chronic sleep-onset insomnia. Methods This was a randomized, placebo-controlled clinical trial that involved 63 young and middle-aged adults with chronic sleep-onset insomnia. Interventions included cognitive behavior therapy (CBT), pharmacotherapy, or combination therapy compared with placebo. The main outcome measures were sleep-onset latency as measured by sleep diaries; secondary measures included sleep diary measures of sleep efficiency and total sleep time, objective measures of sleep variables (Nightcap sleep monitor recorder), and measures of daytime functioning. Results In most measures, CBT was the most sleep effective intervention; it produced the greatest changes in sleep-onset latency and sleep efficiency, yielded the largest number of normal sleepers after treatment, and maintained therapeutic gains at long-term follow-up. The combined treatment provided no advantage over CBT alone, whereas pharmacotherapy produced only moderate improvements during drug administration and returned measures toward baseline after drug use discontinuation. Conclusi…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“CBTi is a first-line treatment with sufficient empirical support to be recommended for treating chronic insomnia [20].”
From Tamper-Resistant Mobile Health Using Blockchain Technology. (2017) · cites this paper as [20]
In the citing paper
“Cognitive Behavioral Therapy for Insomnia (CBT-I) is a non-pharmacological treatment that modifies dysfunctional behaviors and cognition regarding sleep, and is traditionally suggested as the first-line of treatment in the United States and Europe.1”
From Comparison of Acceptance and Commitment Therapy (ACT) and Cognitive Behavior Therapy (CBT) for Chronic Insomnia: A Pilot Randomized Controlled Trial (2023) · cites this paper as [1]
In the citing paper
“Notably, pharmacotherapy produced only moderate improvements that were limited to the duration of drug administration.”
From Cognitive behavioral therapy and acceptance and commitment therapy for the discontinuation of long-term benzodiazepine use in insomnia and anxiety disorders (2021) · cites this paper as [99]
In the citing paper
“Three RCTs [99,100,101] which compared CBT-I, BZD and placebo for chronic insomnia all show that CBT-I was the most effective sleep intervention.”
From Cognitive behavioral therapy and acceptance and commitment therapy for the discontinuation of long-term benzodiazepine use in insomnia and anxiety disorders (2021) · cites this paper as [99]
In the citing paper
“short-term pharmacological treatments alone are effective during the course of treatment for chronic insomnia”
From Clinical Guideline for the Evaluation and Management of Chronic Insomnia in Adults (2008) · cites this paper as [65]
In the citing paper
“but do not provide sustained improvement following discontinuation, 65,66”
From Clinical Guideline for the Evaluation and Management of Chronic Insomnia in Adults (2008) · cites this paper as [65]
In the citing paper
“Taken as a whole, these investigations do not demonstrate a clear advantage for combined treatment over cognitive behavioral treatment alone. 65,66,68-70”
From Clinical Guideline for the Evaluation and Management of Chronic Insomnia in Adults (2008) · cites this paper as [65]
In the citing paper
“A similar association was found in older, but not middle-aged, adults (n = 154) (125) and was recently also reported in children (n = 1,567)”
From The Sleep-Immune Crosstalk in Health and Disease (2019) · cites this paper as [271]
In the citing paper
“The recommended first-line treatment, Cognitive Behavioral Therapy for Insomnia (CBTI) does not carry these risks and is therefore preferable for reasons beyond demonstrated efficacy(244-248), efficacy relative to medications(249-253), and effectiveness(254).”
From Sleep: important considerations for the prevention of cardiovascular disease (2016) · cites this paper as [250]
In the citing paper
“The trials compared CBT-I to zopiclone [29], zolpidem [30], temazepam [31,32], and triazolam [33].”
From Comparative effectiveness of cognitive behavioral therapy for insomnia: a systematic review (2012) · cites this paper as [30]
In the citing paper
“Sleep latency percentage change based on sleep diary revealed pre-to post-treatment effect sizes for the CBTI group (Cohen's d01.17), combined CBTI and medication group (d 01.08), and medication group (d00.51).At follow-up, increased sleep latency was seen in the medication group and the combined CBTI and medication group, as compared with the CBTI only group.”
From Non-Pharmacological Treatment of Insomnia (2012) · cites this paper as [34]
Citations
Cites
McNair, D. M. (1992) · Medical Entomology and Zoology · Cited by 2,527
International Classification of Sleep Disorders
Thorpy, M. (2017) · Sleep Disorders Medicine · doi:10.1007/978-1-4939-6578-6_27 · Cited by 2,505
The Structured Clinical Interview for DSM-III-R (SCID)
Williams, J. B. W. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820080038006 · Cited by 1,641
Nonpharmacological interventions for insomnia: a meta-analysis of treatment efficacy
(1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.8.1172 · Cited by 1,098
Behavioral and Pharmacological Therapies for Late-Life Insomnia: A Randomized Controlled Trial
Morin, C. M., Colecchi, C., Stone, J., Sood, R., & Brink, D. (1999) · JAMA · doi:10.1001/jama.281.11.991 · Cited by 1,095
Insomnia and Its Treatment: Prevalence and Correlates
Mellinger, G. D. (1985) · Archives of General Psychiatry · doi:10.1001/archpsyc.1985.01790260019002 · Cited by 1,071
Identifying effective psychological treatments for insomnia: A meta-analysis.
Murtagh, D. R. R., & Greenwood, K. M. (1995) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.63.1.79 · Cited by 664
Edinger, J. D., Wohlgemuth, W. K., Radtke, R. A., Marsh, G. R., & Quillian, R. E. (2001) · JAMA · doi:10.1001/jama.285.14.1856 · Cited by 625
Benzodiazepines and Zolpidem for Chronic Insomnia: A Meta-analysis of Treatment Efficacy
Nowell, P. D. (1997) · JAMA · doi:10.1001/jama.1997.03550240060035 · Cited by 451
Holm, K. J., & Goa, K. L. (2000) · Drugs · doi:10.2165/00003495-200059040-00014 · Cited by 317
Kupfer, D. J., & Reynolds, C. F. (1997) · New England Journal of Medicine · doi:10.1056/nejm199701303360506 · Cited by 293
Applications of the Beck Depression Inventory
Steer, R. A., Beck, A. T., & Garrison, B. (1986) · Springer eBooks · doi:10.1007/978-3-642-70486-4_13 · Cited by 268
Behavioral Pharmacology of Zolpidem Relative to Benzodiazepines A Review
Rush, C. R. (1998) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(98)00102-6 · Cited by 260
The Diagnosis and Management of Insomnia
Oates, J. A., Wood, A. J. J., Gillin, J. C., & Byerley, W. F. (1990) · New England Journal of Medicine · doi:10.1056/nejm199001253220406 · Cited by 220
Estimating sleep parameters: A multitrait-multimethod analysis.
Coates, T. J., Killen, J. D., George, J., Marchini, E., Silverman, S., & Thoresen, C. E. (1982) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.50.3.345 · Cited by 211
Biopsychobehavioral correlates of insomnia, V: Clinical characteristics and behavioral correlates
Kales, J. D., Kales, A., Bixler, E. O., Soldatos, C. R., Cadieux, R. J., Kashurba, G., & Vela‐Bueno, A. (1984) · American Journal of Psychiatry · doi:10.1176/ajp.141.11.1371 · Cited by 153
The safety and tolerability of zolpidem — an update
DARCOURT, G., Pringuey, D., Sallière, D., & Lavoisy, J. (1999) · Journal of Psychopharmacology · doi:10.1177/026988119901300109 · Cited by 139
Benzodiazepine withdrawal: Overview and implications for the treatment of anxiety
Roy‐Byrne, P., & Hommer, D. (1988) · The American Journal of Medicine · doi:10.1016/0002-9343(88)90309-9 · Cited by 115
Nightcap: Laboratory and home‐based evaluation of a portable sleep monitor
Ajilore, O., Stickgold, R., Rittenhouse, C. D., & Hobson, J. A. (1995) · Psychophysiology · doi:10.1111/j.1469-8986.1995.tb03410.x · Cited by 100
Self-citationEffect of Gradual Withdrawal on the Rebound Sleep Disorder after Discontinuation of Triazolam
Greenblatt, D. J., Harmatz, J. S., Zinny, M. A., & Shader, R. I. (1987) · New England Journal of Medicine · doi:10.1056/nejm198709173171202 · Cited by 96
Jacobs, G. D., Benson, H., & Friedman, R. (1993) · Behavior Therapy · doi:10.1016/s0005-7894(05)80261-8 · Cited by 93
Self-citationClinical decision-making in the evaluation and treatment of insomnia
Everitt, D. E., Avorn, J., & Baker, M. W. (1990) · The American Journal of Medicine · doi:10.1016/0002-9343(90)90349-i · Cited by 93
Behavioral and Pharmacological Treatments for Insomnia
Morin, C. M., & Kwentus, J. A. (1988) · Annals of Behavioral Medicine · doi:10.1207/s15324796abm1003_1 · Cited by 60
Perceived benefits in a behavioral-medicine insomnia program: A clinical report
Jacobs, G. D., Benson, H., & Friedman, R. B. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)89461-2 · Cited by 42
Self-citationHow “Blind” Are Double-Blind Placebo-Controlled Trials of Benzodiazepine Hypnotics?
Morin, C. M., Colecchi, C. A., Brink, D., Astruc, M., Mercer, J., & Remsberg, S. (1995) · SLEEP · doi:10.1093/sleep/18.4.240 · Cited by 31
Diagnosis and Management of Insomnia
Byerley, B., & Gillin, J. C. (1984) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(18)30729-9 · Cited by 13
Flagged first, then by citations
Cited by
Sorted by citations
Qaseem, A., Kansagara, D., Forciea, M. A., Cooke, M., Denberg, T. D., & for the Clinical Guidelines Committee of the American College of Physicians* (2016) · Annals of Internal Medicine · doi:10.7326/m15-2175 · Cited by 1,965
Clinical Guideline for the Evaluation and Management of Chronic Insomnia in Adults
Schutte-Rodin, S., Broch, L., Buysse, D., Dorsey, C., & Sateia, M. (2008) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.27286 · Cited by 1,943
Sateia, M. J., Buysse, D. J., Krystal, A. D., Neubauer, D. N., & Heald, J. L. (2017) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.6470 · Cited by 1,519
The Sleep-Immune Crosstalk in Health and Disease
Besedovsky, L., Lange, T., & Haack, M. (2019) · Physiological Reviews · doi:10.1152/physrev.00010.2018 · Cited by 1,479
“CBT for insomnia (CBT-I) is considered the first-line treatment for insomnia (557) and outperforms pharmacological interventions, in particular with respect to maintenance of therapeutic effects at long-term follow-up (270, 513).”
BackgroundPsychological and behavioral treatment of insomnia: update of the recent evidence (1998-2004)
Morin, C. M., Bootzin, R. R., Buysse, D. J., Edinger, J. D., Espie, C. A., & Lichstein, K. L. (2006) · Sleep · doi:10.1093/sleep/29.11.1398 · Cited by 1,345
Metadata
- Authors
- Jacobs, G. D., Pace-Schott, E. F., Stickgold, R., & Otto, M. W.
- Affiliations
- Beth Israel Deaconess Medical Center (US)
- Venue
- Archives of Internal Medicine
- Publisher
- American Medical Association (AMA)
- Published
- 2004-09-27
- Volume
- 164
- Issue
- 17
- Pages
- 1888
- ISSN
- 0003-9926 (ISSN-L)
- OpenAlex
- W2172054698
- Cited by
- 579
- References
- 26
- Citations by year
- 2026: 13 · 2025: 15 · 2024: 14 · 2023: 23 · 2022: 23 · 2021: 30 · 2020: 15 · 2019: 30 · 2018: 22 · 2017: 25 · 2016: 41 · 2015: 35 · 2014: 26 · 2013: 24 · 2012: 39
- FWCI
- 34.96
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Archives of Internal Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r29hl059387-04)
- National Heart, Lung, and Blood Institute (HL59387)
- National Institute on Drug Abuse (DA117440)
- Topics
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Health Sciences › Medicine › Physiology (medical) › Obstructive Sleep Apnea Research
- Keywords
- chronic insomnia, sleep onset insomnia, cognitive behavioral therapy, pharmacotherapy, combination therapy, sleep latency, sleep efficiency, daytime functioning, treatment efficacy, young and middle-aged adults
- MeSH terms
- Zolpidem, Adult, Combined Modality Therapy, Double-Blind Method, Female, Follow-Up Studies, Humans, Hypnotics and Sedatives, Sleep Initiation and Maintenance Disorders, Male, Middle Aged, Prospective Studies, Pyridines, Cognitive Behavioral Therapy, Treatment Outcome, Polysomnography
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
